Purple Biotech Ltd (TLV: PPBT)
Israel
· Delayed Price · Currency is ILS · Price in ILA
6.90
-0.30 (-4.17%)
Dec 18, 2024, 5:24 PM IDT
Purple Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 5.44 | 14.49 | 15.03 | 10.89 | 11.25 | 4.39 | Upgrade
|
Short-Term Investments | 0.86 | 0.92 | 17.08 | 36.31 | 46.56 | 0.01 | Upgrade
|
Cash & Short-Term Investments | 6.3 | 15.41 | 32.11 | 47.2 | 57.81 | 4.4 | Upgrade
|
Cash Growth | -60.83% | -52.01% | -31.96% | -18.35% | 1215.24% | -34.25% | Upgrade
|
Accounts Receivable | - | - | - | - | 0.5 | - | Upgrade
|
Other Receivables | - | - | - | - | - | 1.49 | Upgrade
|
Receivables | - | - | - | - | 0.5 | 3.49 | Upgrade
|
Prepaid Expenses | - | 0.21 | 1 | 1.01 | 0.78 | 0.23 | Upgrade
|
Other Current Assets | 0.64 | 0.17 | 0.15 | 0.27 | 0.2 | 0.18 | Upgrade
|
Total Current Assets | 6.94 | 15.79 | 33.26 | 48.47 | 59.28 | 8.3 | Upgrade
|
Property, Plant & Equipment | 0.33 | 0.47 | 0.68 | 0.9 | 0.97 | 0.24 | Upgrade
|
Long-Term Investments | - | - | - | 0.19 | - | - | Upgrade
|
Other Intangible Assets | 27.84 | 28.04 | 20.68 | 20.48 | 20.48 | 6.17 | Upgrade
|
Other Long-Term Assets | - | - | - | 0.16 | 3.07 | - | Upgrade
|
Total Assets | 35.11 | 44.3 | 54.62 | 70.2 | 83.8 | 14.72 | Upgrade
|
Accounts Payable | 1.91 | 3.53 | 2.13 | 1.47 | 1.2 | 1.25 | Upgrade
|
Accrued Expenses | - | 3.46 | 4.72 | 2.56 | 1.69 | 1.15 | Upgrade
|
Current Portion of Leases | 0.18 | 0.19 | 0.19 | 0.2 | 0.21 | 0.2 | Upgrade
|
Current Unearned Revenue | - | - | - | - | - | 0.96 | Upgrade
|
Other Current Liabilities | 3.36 | - | 0.01 | 0.02 | - | - | Upgrade
|
Total Current Liabilities | 5.46 | 7.18 | 7.06 | 4.25 | 3.1 | 3.55 | Upgrade
|
Long-Term Leases | 0.04 | 0.16 | 0.32 | 0.55 | 0.69 | 0.03 | Upgrade
|
Other Long-Term Liabilities | - | 2.52 | - | - | - | - | Upgrade
|
Total Liabilities | 5.64 | 10.01 | 7.52 | 5.09 | 4.05 | 3.86 | Upgrade
|
Additional Paid-In Capital | 143.65 | 133.18 | 126.41 | 123.95 | 118.91 | 46.99 | Upgrade
|
Retained Earnings | -144.28 | -137.45 | -117.57 | -95.91 | -77.52 | -49.52 | Upgrade
|
Comprehensive Income & Other | 30.05 | 38.48 | 38.08 | 36.78 | 38 | 12.96 | Upgrade
|
Total Common Equity | 29.41 | 34.21 | 46.91 | 64.83 | 79.39 | 10.42 | Upgrade
|
Minority Interest | 0.06 | 0.09 | 0.19 | 0.28 | 0.36 | 0.44 | Upgrade
|
Shareholders' Equity | 29.47 | 34.3 | 47.1 | 65.11 | 79.75 | 10.86 | Upgrade
|
Total Liabilities & Equity | 35.11 | 44.3 | 54.62 | 70.2 | 83.8 | 14.72 | Upgrade
|
Total Debt | 0.22 | 0.35 | 0.52 | 0.75 | 0.9 | 0.22 | Upgrade
|
Net Cash (Debt) | 6.08 | 15.06 | 31.6 | 46.45 | 56.91 | 4.17 | Upgrade
|
Net Cash Growth | -61.32% | -52.34% | -31.98% | -18.38% | 1264.09% | -37.58% | Upgrade
|
Net Cash Per Share | 0.03 | 0.07 | 0.17 | 0.26 | 0.49 | 0.22 | Upgrade
|
Filing Date Shares Outstanding | 1.73 | 265.58 | 207.87 | 178.26 | 175.11 | 40.46 | Upgrade
|
Total Common Shares Outstanding | 1.73 | 252.38 | 184.82 | 178 | 172.11 | 19.56 | Upgrade
|
Working Capital | 1.48 | 8.61 | 26.2 | 44.22 | 56.18 | 4.76 | Upgrade
|
Book Value Per Share | 16.98 | 0.14 | 0.25 | 0.36 | 0.46 | 0.53 | Upgrade
|
Tangible Book Value | 1.57 | 6.16 | 26.23 | 44.35 | 58.91 | 4.25 | Upgrade
|
Tangible Book Value Per Share | 0.91 | 0.02 | 0.14 | 0.25 | 0.34 | 0.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.